A Small Step

GlaxoSmithKline plans to open its labs to outside, nonprofit collaborators to spur research into malaria and other neglected diseases, Chief Executive Andrew Witty told Forbes. One such project for therapies to treat parasitic worms is being carried out in conjunction with Emory University researchers and Alnylam Pharmaceuticals. “GSK is providing us direct access to the scientists and all of the [internal] reports in the program. ...

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.